vs
Esperion Therapeutics, Inc.（ESPR）与FIRSTSUN CAPITAL BANCORP（FSUN）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是FIRSTSUN CAPITAL BANCORP的1.5倍（$168.4M vs $110.0M），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 6.9%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
FirstSun Capital Bancorp是一家总部位于美国的金融控股公司，提供商业及个人贷款、存款产品、财富管理、财资解决方案等全面的银行金融服务，主要面向美国区域市场的个人消费者、中小企业及企业客户。
ESPR vs FSUN — 直观对比
营收规模更大
ESPR
是对方的1.5倍
$110.0M
两年增速更快
ESPR
近两年复合增速
6.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $110.0M |
| 净利润 | — | $21.6M |
| 毛利率 | — | — |
| 营业利润率 | 50.6% | — |
| 净利率 | — | 19.6% |
| 营收同比 | 143.7% | — |
| 净利润同比 | — | -8.4% |
| 每股收益（稀释后） | $0.32 | $0.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRFSUN
| Q1 26 | — | $110.0M | ||
| Q4 25 | $168.4M | $110.2M | ||
| Q3 25 | $87.3M | $107.3M | ||
| Q2 25 | $82.4M | $105.6M | ||
| Q1 25 | $65.0M | $96.2M | ||
| Q4 24 | $69.1M | $98.7M | ||
| Q3 24 | $51.6M | $98.2M | ||
| Q2 24 | $73.8M | $96.2M |
净利润ESPRFSUN
| Q1 26 | — | $21.6M | ||
| Q4 25 | — | $24.8M | ||
| Q3 25 | $-31.3M | $23.2M | ||
| Q2 25 | $-12.7M | $26.4M | ||
| Q1 25 | $-40.5M | $23.6M | ||
| Q4 24 | — | $16.4M | ||
| Q3 24 | $-29.5M | $22.4M | ||
| Q2 24 | $-61.9M | $24.6M |
营业利润率ESPRFSUN
| Q1 26 | — | — | ||
| Q4 25 | 50.6% | 29.0% | ||
| Q3 25 | -11.4% | 26.4% | ||
| Q2 25 | 8.6% | 31.2% | ||
| Q1 25 | -34.0% | 30.9% | ||
| Q4 24 | -6.4% | 20.4% | ||
| Q3 24 | -31.0% | 29.1% | ||
| Q2 24 | 3.5% | 32.3% |
净利率ESPRFSUN
| Q1 26 | — | 19.6% | ||
| Q4 25 | — | 22.5% | ||
| Q3 25 | -35.9% | 21.6% | ||
| Q2 25 | -15.4% | 25.0% | ||
| Q1 25 | -62.2% | 24.5% | ||
| Q4 24 | — | 16.6% | ||
| Q3 24 | -57.2% | 22.8% | ||
| Q2 24 | -83.9% | 25.5% |
每股收益（稀释后）ESPRFSUN
| Q1 26 | — | $0.76 | ||
| Q4 25 | $0.32 | $0.89 | ||
| Q3 25 | $-0.16 | $0.82 | ||
| Q2 25 | $-0.06 | $0.93 | ||
| Q1 25 | $-0.21 | $0.83 | ||
| Q4 24 | $-0.14 | $0.57 | ||
| Q3 24 | $-0.15 | $0.79 | ||
| Q2 24 | $-0.33 | $0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $413.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-302.0M | $1.2B |
| 总资产 | $465.9M | $8.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRFSUN
| Q1 26 | — | $413.7M | ||
| Q4 25 | $167.9M | $652.6M | ||
| Q3 25 | $92.4M | $659.9M | ||
| Q2 25 | $86.1M | $785.1M | ||
| Q1 25 | $114.6M | $621.4M | ||
| Q4 24 | $144.8M | $615.9M | ||
| Q3 24 | $144.7M | $573.7M | ||
| Q2 24 | $189.3M | $535.8M |
股东权益ESPRFSUN
| Q1 26 | — | $1.2B | ||
| Q4 25 | $-302.0M | $1.2B | ||
| Q3 25 | $-451.4M | $1.1B | ||
| Q2 25 | $-433.5M | $1.1B | ||
| Q1 25 | $-426.2M | $1.1B | ||
| Q4 24 | $-388.7M | $1.0B | ||
| Q3 24 | $-370.2M | $1.0B | ||
| Q2 24 | $-344.2M | $996.6M |
总资产ESPRFSUN
| Q1 26 | — | $8.6B | ||
| Q4 25 | $465.9M | $8.5B | ||
| Q3 25 | $364.0M | $8.5B | ||
| Q2 25 | $347.1M | $8.4B | ||
| Q1 25 | $324.0M | $8.2B | ||
| Q4 24 | $343.8M | $8.1B | ||
| Q3 24 | $314.1M | $8.1B | ||
| Q2 24 | $352.3M | $8.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ESPRFSUN
| Q1 26 | — | — | ||
| Q4 25 | $45.2M | $111.5M | ||
| Q3 25 | $-4.3M | $49.4M | ||
| Q2 25 | $-31.4M | $15.0M | ||
| Q1 25 | $-22.6M | $26.4M | ||
| Q4 24 | $-35.0M | $101.1M | ||
| Q3 24 | $-35.3M | $48.1M | ||
| Q2 24 | $-7.2M | $20.9M |
自由现金流ESPRFSUN
| Q1 26 | — | — | ||
| Q4 25 | — | $104.0M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | — | $13.0M | ||
| Q1 25 | — | $24.3M | ||
| Q4 24 | — | $95.7M | ||
| Q3 24 | $-35.5M | $47.1M | ||
| Q2 24 | $-7.3M | $19.9M |
自由现金流率ESPRFSUN
| Q1 26 | — | — | ||
| Q4 25 | — | 94.3% | ||
| Q3 25 | — | 44.4% | ||
| Q2 25 | — | 12.3% | ||
| Q1 25 | — | 25.3% | ||
| Q4 24 | — | 97.0% | ||
| Q3 24 | -68.7% | 47.9% | ||
| Q2 24 | -9.9% | 20.6% |
资本支出强度ESPRFSUN
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 6.8% | ||
| Q3 25 | 0.0% | 1.6% | ||
| Q2 25 | 0.0% | 1.9% | ||
| Q1 25 | 0.0% | 2.1% | ||
| Q4 24 | 0.0% | 5.5% | ||
| Q3 24 | 0.3% | 1.1% | ||
| Q2 24 | 0.1% | 1.1% |
现金转化率ESPRFSUN
| Q1 26 | — | — | ||
| Q4 25 | — | 4.49× | ||
| Q3 25 | — | 2.13× | ||
| Q2 25 | — | 0.57× | ||
| Q1 25 | — | 1.12× | ||
| Q4 24 | — | 6.18× | ||
| Q3 24 | — | 2.15× | ||
| Q2 24 | — | 0.85× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
FSUN
| Net Interest Income | $82.8M | 75% |
| Noninterest Income | $27.2M | 25% |
